John Z Metcalfe

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice
    John Z Metcalfe
    University of California, San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Room 5K1, San Francisco, CA 94110 0111, USA
    Am J Respir Crit Care Med 187:206-11. 2013
  2. ncbi Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects
    John Z Metcalfe
    San Francisco General Hospital, University of California, 94110 0111, USA
    Am J Respir Crit Care Med 181:87-93. 2010
  3. ncbi Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007
    John Z Metcalfe
    University of California, San Francisco, California, USA
    Emerg Infect Dis 16:1403-9. 2010
  4. ncbi Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis
    John Z Metcalfe
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA, USA
    J Infect Dis 204:S1120-9. 2011
  5. ncbi Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
  6. ncbi Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies
    Midori Kato-Maeda
    University of California, San Francisco, Francis J Curry National Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Building 100, Room 109, Mail Box 0841, San Francisco, CA 94110 0111, USA
    Future Microbiol 6:203-16. 2011
  7. ncbi Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 56:230-8. 2011
  8. ncbi A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa
    Elvin H Geng
    Division of HIV AIDS and Infectious Diseases, San Francisco General Hospital, Department of Medicine, School of Medicine, University of California, San Francisco, 995 Potrero Avenue, Building 80, Box 0874, San Francisco, CA 94110, USA
    Am J Epidemiol 175:1080-7. 2012
  9. ncbi Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study
    J Lucian Davis
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 5:e9859. 2010

Detail Information

Publications9

  1. ncbi Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice
    John Z Metcalfe
    University of California, San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Room 5K1, San Francisco, CA 94110 0111, USA
    Am J Respir Crit Care Med 187:206-11. 2013
    ..Although IFN-γ release assays (IGRAs) are widely used to screen for Mycobacterium tuberculosis infection in high-income countries, published data on repeatability are limited...
  2. ncbi Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects
    John Z Metcalfe
    San Francisco General Hospital, University of California, 94110 0111, USA
    Am J Respir Crit Care Med 181:87-93. 2010
    ..Objectives: To determine whether the addition of quantitative IGRA results to a prediction model incorporating clinical criteria improves risk stratification of smear-negative-tuberculosis suspects...
  3. ncbi Determinants of multidrug-resistant tuberculosis clusters, California, USA, 2004-2007
    John Z Metcalfe
    University of California, San Francisco, California, USA
    Emerg Infect Dis 16:1403-9. 2010
    ..In multivariate analysis, the katG S315T mutation (odds ratio 11.2, 95% confidence interval 2.2-Yen; p = 0.004), but not strain lineage, was independently associated with case clustering...
  4. ncbi Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis
    John Z Metcalfe
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, San Francisco, CA, USA
    J Infect Dis 204:S1120-9. 2011
    ..The diagnostic value of interferon-γ release assays (IGRAs) for active tuberculosis in low- and middle-income countries is unclear...
  5. ncbi Clinical characteristics and treatment outcomes of patients with isoniazid-monoresistant tuberculosis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco GeneralHospital, 1001 Potrero Ave, San Francisco, CA 94110, USA
    Clin Infect Dis 48:179-85. 2009
    ..Risk factors and treatment outcomes under program conditions for isoniazid (INH)-monoresistant tuberculosis have not been well described...
  6. ncbi Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies
    Midori Kato-Maeda
    University of California, San Francisco, Francis J Curry National Tuberculosis Center, Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, 1001 Potrero Avenue, Building 100, Room 109, Mail Box 0841, San Francisco, CA 94110 0111, USA
    Future Microbiol 6:203-16. 2011
    ..In this article, we review the genetic markers used in molecular epidemiologic studies including the use of whole-genome sequencing technology. We also review the public health application of molecular epidemiologic tools...
  7. ncbi Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis
    Adithya Cattamanchi
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 56:230-8. 2011
    ..To determine whether interferon-gamma release assays (IGRAs) improve the identification of HIV-infected individuals who could benefit from latent tuberculosis infection therapy...
  8. ncbi A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa
    Elvin H Geng
    Division of HIV AIDS and Infectious Diseases, San Francisco General Hospital, Department of Medicine, School of Medicine, University of California, San Francisco, 995 Potrero Avenue, Building 80, Box 0874, San Francisco, CA 94110, USA
    Am J Epidemiol 175:1080-7. 2012
    ..A sampling-based approach can in general strengthen epidemiologic analyses conducted in many clinic-based cohorts, including those examining other diseases...
  9. ncbi Clinical and radiographic factors do not accurately diagnose smear-negative tuberculosis in HIV-infected inpatients in Uganda: a cross-sectional study
    J Lucian Davis
    Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 5:e9859. 2010
    ..Therefore, we sought to assess the accuracy of symptoms, physical signs, and radiographic findings for diagnosing tuberculosis in this population in a low-income country with a high incidence of tuberculosis...